Charles J. "Chuck" Fleischmann
Suspicious Timing Detected
5 flagsRep. Fleischmann sold $1,001 - $15,000 in $ACN on February 23, 2026 — 2 days before the Information Quality Assurance Act of 2025 (HR6329) was introduced, a bill requiring federal agencies to update data quality guidelines.
Rep. Fleischmann sold $1,001 - $15,000 in $ACN on February 23, 2026 — 9 days before the Federal Loan Systems Modernization Act of 2026 (HR7789) was introduced, which could create direct contracting opportunities for government IT service providers.
Rep. Fleischmann sold $1,001 - $15,000 in $PYPL on February 20, 2026 — 12 days before the Main Street Capital Access Act (HR6955) was introduced, a bill that could deregulate the banking sector.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| SELL | $ADBE | Adobe Sys Inc Com (ADBE) | $1K-$15K | — | — | — | Feb 20, 2026 |
| SELL | $EEFT | Euronet Worldwide Inc Com (EEFT) | $1K-$15K | — | — | — | Feb 20, 2026 |
| SELL | $PYPL | Paypal Hidgs Inc Com (PYPL) | $1K-$15K | — | — | — | Feb 20, 2026 |
| SELL | $PINS | Pinterest Inc CLA (PINS) | $1K-$15K | — | — | — | Feb 20, 2026 |
| SELL | $NOW | Servicenow Inc Com (NOW) | $1K-$15K | — | — | — | Feb 20, 2026 |
| SELL | $UNH | United Health Group Inc Com (UNH) | $1K-$15K | — | — | — | Feb 20, 2026 |
| SELL | $ACN | Accenture PLC Ireland SHS CL A (ACN) | $1K-$15K | — | — | — | Feb 23, 2026 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
A bill to establish standards and guidelines to make open Government data assets artificial intelligence-ready, and for other purposes.
S.4098, the Artificial Intelligence-Ready Data Act, has been introduced in the Senate and referred to committee. This bill directs NIST to develop standards for making government data AI-ready, which could create new market opportunities for technology and consulting firms specializing in data management and AI solutions. No specific funding is authorized by this bill.
Living Donor Protection Act of 2025
The Living Donor Protection Act of 2025 removes insurance discrimination barriers for living organ donors, directly increasing the pool of eligible donors and the volume of transplant procedures. This legislation expands the market for organ transplantation services and associated insurance products. Healthcare providers and life/disability/long-term care insurers will see increased demand and reduced risk.
To amend title XXVII of the Public Health Service Act and the Patient Protection and Affordable Care Act to provide for certain reforms with respect to medical loss ratios and reducing fraudulent enrollment in qualified health plans.
HR7861, the 'Care Over Profits Act of 2026,' increases the minimum medical loss ratio to 85% for small group and individual health insurance markets and imposes new penalties for fraudulent enrollment. This legislation, if enacted, would directly reduce health insurers' profit margins and increase compliance costs. Despite the negative outlook presented by the bill, major health insurance stocks have shown positive 7-day changes, with $UNH up +7.48%, $ELV up +6.26%, $CI up +6.82%, and $HUM up +10.03%.
Federal Loan Systems Modernization Act of 2026
The Federal Loan Systems Modernization Act of 2026 creates direct contracting opportunities for government IT service providers and enterprise software companies by mandating the creation of a centralized federal loan platform, Lending.gov. This bill establishes a new federal IT infrastructure project without specific appropriations, directing the GSA to manage its implementation.
Information Quality Assurance Act of 2025
The Information Quality Assurance Act of 2025 (HR6329) is in an early legislative stage, requiring federal agencies to update data quality guidelines. If enacted, this bill would increase demand for information management and data quality services from federal agencies, potentially benefiting technology companies like $IBM, $ACN, $MSTR, and $ORCL. Recent market performance for these companies shows mixed results, with 7-day gains for $IBM and $MSTR, and 7-day declines for $ACN and $ORCL, while all four show 30-day declines.
To amend the Patient Protection and Affordable Care Act to address fraudulent enrollments in the Exchanges.
HR7860, the 'Stop ACA Enrollment Fraud Act of 2026,' aims to prevent duplicate enrollments and mandate agent consent within ACA Exchanges. This bill, currently in early stages, could reduce fraud risk for health insurers while increasing administrative burdens for brokers and potentially consumers. The market has seen recent positive movement in healthcare stocks, with UNH, HUM, and CI showing 7-day gains of +7.48%, +10.03%, and +6.82% respectively.
Main Street Capital Access Act
The Main Street Capital Access Act, HR6955, significantly deregulates the banking sector, increasing lending capacity and profitability for financial institutions. This bill's passage out of committee indicates high legislative momentum, directly benefiting banks and fintech companies.
To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
This bill directly withdraws FDA approval for mifepristone, eliminating its market and establishing a federal tort for chemical abortion drug harm. This action shifts demand to surgical abortion services and emergency care, creating significant financial and operational challenges for healthcare providers and pharmaceutical companies.
PBM Kickback Prohibition Act
The PBM Kickback Prohibition Act directly prohibits compensation for referrals to PBMs, eliminating a significant revenue stream for integrated healthcare companies. This legislation increases financial pressure on major PBM operators and their parent companies. Pharmaceutical manufacturers will experience increased pricing flexibility due to reduced PBM leverage.
Children and Teens’ Online Privacy Protection Act
The Children and Teens’ Online Privacy Protection Act (S836) has passed the Senate and is now in the House, indicating significant legislative momentum. This bill directly targets the data collection and advertising revenue models of major technology companies, increasing operational costs and compliance burdens. Recent market data shows a mixed reaction, with $GOOGL, $META, $SNAP, $PINS, and $AMZN experiencing varied 7-day and 30-day price changes, but the long-term implications of this bill are negative for their core business models.
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.